S AT U R DAY, J U LY 2 4 , 2 0 2 1 | A S C R S A N N UA L M E E T I N G
DAILY NEWS
Dr. McDonald delivers the Steinert Refractive
Lecture on presbyopia correction options for
phakic individuals.
Source: ASCRS
continued on page 4
continued on page 3
T
he Stephen A. Obstbaum,
MD, Honored Lecture took
on a different format this
year. Past leadership from
the ASCRS Glaucoma Clinical
Committee—Reay Brown, MD,
Richard Lewis, MD, Thomas
Samuelson, MD, and Douglas
Rhee, MD—and moderator Leon
Herndon, MD, current chair of
the Glaucoma Clinical Committee,
shared an aspect of their career
that they're most proud of.
Dr. Brown spoke about the
many procedures and devices he
was involved in researching. The
one he said he is most proud of
is EyePass, which he described as
the first trabecular bypass device.
He worked on this from 1999–
2006, went through three FDA
studies, but ran out of financing
and was not successful with it.
However, this work led to some of
the fundamental paths and under-
standing of trabecular bypass.
Dr. Lewis focused his presen-
tation on changes in canaloplasty.
Canal surgery is not new, he said,
noting that it's been going on for
60 years and giving a history of its
clinical milestones. Early on, Dr.
Lewis said canaloplasty met resis-
tance within the subspecialty, but
it persevered as a procedure.
"We had a few early adopters
but a lot of negative feedback.
Panelists share proudest career moments in Obstbaum lecture
Marguerite McDonald, MD,
delivers Steinert Refractive Lecture
OT
1
BVI
1
Visit Booth 5208 to Hear
What's New at BVI
BVI and all other trademarks (unless noted otherwise) are property of BVI. BVI ©2021
FOR MORE INFORMATION,
VISIT US AT BOOTH #5201
SO YOUR PATIENTS
DON'T HAVE TO
© 2021 Ocular Therapeutix, Inc. All rights reserved. DEXTENZA is a registered trademark of Ocular Therapeutix, Inc. PP-US-DX-0323
M
arguerite McDonald,
MD, gave the Steinert
Refractive Lecture at Re-
fractive Day, describing
it as a pleasure to be selected to
honor "this brilliant clinician-sci-
entist," Roger Steinert, MD. Her
talk focused on the current and
future treatments of presbyopia
for phakic patients.
Current solutions include
glasses, contact lenses, and
